Epidemiological and Molecular Colorectal Cancer Registry (EMR-CRC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02781337|
Recruitment Status : Recruiting
First Posted : May 24, 2016
Last Update Posted : May 24, 2016
|Condition or disease|
|Colorectal Neoplasms Colorectal Cancer|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||600 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||Epidemiological and Molecular Colorectal Cancer Registry|
|Study Start Date :||May 2012|
|Estimated Primary Completion Date :||December 2020|
- Overall survival [ Time Frame: 5 years ]Patient overall survival at 5 years.
- Disease-free survival [ Time Frame: 5 years ]The time free of disease recurrence will be estimated in the whole cohort and according to colorectal cancer stages and molecular profiles.
- Molecular characteristics of colorectal adenocarcinoma. [ Time Frame: 0 ]At initial diagnosis, molecular tumor markers will be determined in the tissue samples.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02781337
|Contact: Carlos Vaccaro, MDemail@example.com|
|Contact: María L González, MDfirstname.lastname@example.org|
|Hospital Italiano de Buenos Aires||Recruiting|
|Caba, Buenos Aires, Argentina|
|Contact: HIBA 54-11-49590200 ext 8863|
|Principal Investigator: Carlos Vaccaro, MD|
|Sub-Investigator: María L González, MD|
|Sub-Investigator: Natalia S Causada Calo, MD|
|Principal Investigator:||Carlos Vaccaro, MD||Hospital Italiano de Buenos Aires|